Taiho Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group develops and markets pharmaceutical products in the field of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical products such as anti-allergic agents, anti-tumor agents, H2 receptor antagonists, antibiotics and medical devices; and consumer health products such as vitamin tonic, herbal digestive medicine, topical analgesics, antifungal cream, herbal medicine powder, and others. Taiho has production facilities in Tokushima, Saitama, Okayama, Kitajima and Inuyama. It operates through its subsidiaries in Japan, China, Singapore, the UK and the US. Taiho is headquartered in Tokyo, Japan.

Taiho Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Taiho Pharma Acquires Fermentation Research-Related Assets from Astellas Pharma 14
Venture Financing 15
Harpoon Therapeutics Raises USD70 Million in Series C Financing 15
ORIC Pharma Raises USD50 Million in Series C Financing 17
Storm Therapeutics Raises Additional USD5.4 Million in Series A Financing 19
Arcus Biosciences Raises USD107 Million in Series C Financing 20
Harpoon Therapeutics Raises USD45 Million in series B Financing 22
Arcus Biosciences Raises USD70 Million in Series B Financing 24
Partnerships 25
Taiho Pharma Enters into Co-Marketing Agreement with Janssen Pharma 25
X-Chem Enters into Agreement with Taiho Pharma 26
Merck Enters into Co-Promotion Agreement with Taiho Pharma for Pembrolizumab 27
Taiho Pharma Enters into Co-Marketing Agreement with Meiji Seika Pharma 28
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 29
Licensing Agreements 30
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 30
TTY Biopharm Enters into Licensing Agreement with Taiho Pharma 31
Taiho Pharma Enters into Licensing Agreement with Servier 32
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 33
Taiho Pharmaceutical Co Ltd - Key Competitors 35
Taiho Pharmaceutical Co Ltd - Key Employees 36
Taiho Pharmaceutical Co Ltd - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Strategy And Business Planning 38
Jun 02, 2017: Taiho Pharmaceutical to Construct Facility for Production of Highly Potent Pharmaceutical Ingredients 38
Mar 07, 2017: Taiho Pharmaceutical Announces Expansion into Canada 39
Product News 40
Oct 05, 2017: Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings 40
May 28, 2018: Taiho Pharmaceutical to Launch Tiovita Drink Aibitasu Zero Nationwide on May 28, 2018 "No fatigue the next day!" 41
Feb 07, 2017: Taiho Pharmaceutical Releases Pure Quick S Ointment, a New Mini Size Steroid Product 42
Clinical Trials 43
Apr 16, 2018: Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy 43
Other Significant Developments 44
Jul 03, 2018: Taiho Pharmaceutical Completes New Production Facility for Highly Potent Pharmaceutical Ingredients at Saitama Site 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables


Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Taiho Pharma Acquires Fermentation Research-Related Assets from Astellas Pharma 14
Harpoon Therapeutics Raises USD70 Million in Series C Financing 15
ORIC Pharma Raises USD50 Million in Series C Financing 17
Storm Therapeutics Raises Additional USD5.4 Million in Series A Financing 19
Arcus Biosciences Raises USD107 Million in Series C Financing 20
Harpoon Therapeutics Raises USD45 Million in series B Financing 22
Arcus Biosciences Raises USD70 Million in Series B Financing 24
Taiho Pharma Enters into Co-Marketing Agreement with Janssen Pharma 25
X-Chem Enters into Agreement with Taiho Pharma 26
Merck Enters into Co-Promotion Agreement with Taiho Pharma for Pembrolizumab 27
Taiho Pharma Enters into Co-Marketing Agreement with Meiji Seika Pharma 28
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 29
Taiho Pharma Enters into Licensing Agreement with Arcus Biosciences 30
TTY Biopharm Enters into Licensing Agreement with Taiho Pharma 31
Taiho Pharma Enters into Licensing Agreement with Servier 32
Taiho Pharma Enters Into Licensing Agreement With Faes Farma For Bilastine 33
Taiho Pharmaceutical Co Ltd, Key Competitors 35
Taiho Pharmaceutical Co Ltd, Key Employees 36
Taiho Pharmaceutical Co Ltd, Subsidiaries 37

List Of Figures


Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Taiho Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Taiho Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Taiho Pharmaceutical Co Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Taiho Pharmaceutical Co Ltd (Taiho), a subsidiary of Otsuka Group develops and markets pharmaceutical products in the field of cancer, allergy, immunology, urology and others. Its product portfolio includes pharmaceutical

USD 250 View Report

Taiho Pharmaceutical Co, Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Taiho Pharmaceutical Co, Ltd Company Profile is a detailed strategic and analytical report on Taiho Pharmaceutical Co, Ltd. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Xiangxue Pharmaceutical Co Ltd (300147) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Xiangxue Pharmaceutical Co Ltd (XPH) is a pharmaceutical company that manufactures and distributes drugs and medicines. The companys products include drugs, Chinese medicine pieces, medical instruments, health products and medicinal

USD 250 View Report

Hunan Fangsheng Pharmaceutical Co Ltd (603998) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hunan Fangsheng Pharmaceutical Co Ltd (Fangsheng Pharma) is a research-based comprehensive pharmaceutical enterprise offers research, development, manufacturing and sales of pharmaceuticals. The enterprise products include tablets, capsules, granules, oral suspension,

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available